Sartorius says one operator can run eight cell therapy patients on Eveo platform at Meeting on the Mesa
Sartorius chief technology officer Oscar-Werner Reif told the Cell & Gene Meeting on the Mesa the company believes its automated Eveo platform can bring cell therapy costs below $40,000 per patient.